Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1011557 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Marcell Crispim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Institute of Biomedical Sciences of the University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Parasites, Pentanols, Diterpenes, Hemiterpenes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Spanish Ministry of Science & Innovation, Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires.
Abstract (Originalsprache)
A proposed treatment for malaria is a combination of fosmidomycin and clindamycin. Both compounds inhibit the methylerythritol 4-phosphate (MEP) pathway, the parasitic source of farnesyl and geranylgeranyl pyrophosphate (FPP and GGPP, respectively). Both FPP and GGPP are crucial for the biosynthesis of several essential metabolites such as ubiquinone and dolichol, as well as for protein prenylation. Dietary prenols, such as farnesol (FOH) and geranylgeraniol (GGOH), can rescue parasites from MEP inhibitors, suggesting the existence of a missing pathway for prenol salvage via phosphorylation. In this study, we identified a gene in the genome of P . falciparum , encoding a transmembrane prenol kinase (PolK) involved in the salvage of FOH and GGOH. The enzyme was expressed in Saccharomyces cerevisiae , and its FOH/GGOH kinase activities were experimentally validated. Furthermore, conditional knockout parasites (Δ-PolK) were created to investigate the biological importance of the FOH/GGOH salvage pathway. Δ-PolK parasites were viable but displayed increased susceptibility to fosmidomycin. Their sensitivity to MEP inhibitors could not be rescued by adding prenols. Additionally, Δ-PolK parasites lost their capability to utilize prenols for protein prenylation. Experiments using culture medium supplemented with whole/delipidated human plasma in transgenic parasites revealed that human plasma has components that can diminish the effectiveness of fosmidomycin. Mass spectrometry tests indicated that both bovine supplements used in culture and human plasma contain GGOH. These findings suggest that the FOH/GGOH salvage pathway might offer an alternate source of isoprenoids for malaria parasites when de novo biosynthesis is inhibited. This study also identifies a novel kind of enzyme related to isoprenoid metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Parasitology, Institute of Biomedical Sciences of the University of São Paulo, São Paulo, Brazil.
- Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
- Center for Biological and Health Sciences, Integrated Unit for Research in Biodiversity (BIOTROP-CCBS), Federal University of São Carlos, São Carlos, Brazil.
- Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tuebingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Tübingen, Germany.
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
- Excellence Cluster "Controlling Microbes to Fight Infections" (CMFI), Tübingen, Germany.
ORCID-Profile: Alejandro Miguel Katzin, Luis Izquierdo
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Spanish Ministry of Science & Innovation
- Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires
- FPU Fellowship from the Spanish Ministry of Universities
- Federal Ministry of Education and Research
- the Baden-Württemberg Ministry of Science
Zitieren
APA
Crispim, M., Verdaguer, I. B., Hernández, A., Kronenberger, T., Fenollar, À., Yamaguchi, L. F., Alberione, M. P., Ramirez, M., de Oliveira, S. S., Katzin, A. M., & Izquierdo, L. (2024). Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011557
Vancouver
Crispim M, Verdaguer IB, Hernández A, Kronenberger T, Fenollar À, Yamaguchi LF, et al. Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011557
BibTeX
@article{Crispim2024,
author = {Crispim, Marcell and Verdaguer, Ignasi Bofill and Hernández, Agustín and Kronenberger, Thales and Fenollar, Àngel and Yamaguchi, Lydia Fumiko and Alberione, María Pía and Ramirez, Miriam and de Oliveira, Sandra Souza and Katzin, Alejandro Miguel and Izquierdo, Luis},
title = {Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1011557}
}
EUVIMED